Daily glucocorticoid dose associates with worse patient reported outcomes in patients from the Almenara Lupus Cohort
{{output}}
Objective: To evaluate the association between the daily GC dose and various patient-reported outcomes (PROs) in patients who have achieved lupus low disease activity state (LLDAS). ... ...
